Torrey Pines Investment will lead, co-lead or take a membership role in an investing syndicate. We are looking for assets with clinical POC achievable within 3 years. We help our portfolio companies with both product and corporate development by leveraging our expertise in drug discovery, including non-clinical and clinical studies, manufacturing and quality, as well as regulatory affairs.
We are committed to capitalizing on the unique investment opportunities in biotech and pharma, where we can add value in development or regulatory strategy by utilizing resources of our portfolio CRO companies.